Overview


According to FutureWise analysis, the market for Fish Skin Disease is expected to grow with a CAGR of 7.1% over the forecast period 2023-2031, and reach a market value of US$ 3.18 Billion by 2031. 

Fish Skin Disease, also known as fish dermatitis or fish epidermal hyperplasia, is a condition that affects various species of fish, particularly those in aquaculture settings. It is characterized by visible abnormalities on the skin and scales, often presenting as lesions, ulcers, discoloration, or changes in texture. This condition can lead to significant health issues for affected fish populations, potentially impacting their growth, behavior, and overall well-being.

The condition arises due to a confluence of factors, which include environmental stressors, pathogenic microorganisms, and compromised immune function. Common contributing factors include poor water quality, overcrowded conditions, improper nutrition, and exposure to pathogens like bacteria, viruses, and parasites. The symptoms and severity of Fish Skin Disease can vary depending on the specific causative agents, environmental conditions, and fish species involved. Early signs may include changes in skin coloration, the appearance of small lesions, or areas of raised tissue. As the disease progresses, these abnormalities may worsen, potentially leading to open sores, tissue erosion, and loss of scales. Managing Fish Skin Disease involves a combination of preventive measures and treatment strategies. These may include maintaining optimal water quality, implementing biosecurity measures, providing proper nutrition, and administering appropriate medications or treatments to affected individuals.

FutureWise Market Research has published a report that provides an insightful analysis of Fish Skin Disease Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts' projects that the Fish Skin Disease Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Zoetis Inc.
  • Elanco Animal Health
  • MSD Animal Health
  • Benchmark Holdings
  • Phibro Animal Health Corporation
  • Intervet Inc.
  • Norvartis
  • Merck Animal Health
  • Novartis AG
  • Pharmaq AS
  • AquaBounty Technologies
  • Alltech
  • Skretting
  • Nutreco
  • Biomin

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Fish Skin Disease Market:

  • In 2021, MSD Animal Health introduced a novel vaccine named AQUAVAC® PD3, offering a safeguard against Piscine orthoreovirus (PRV) and salmonid alphavirus subtype 3 (SAV3) in salmon.

On the driver side, the rising prevalence of skin diseases in fish populations, attributed to environmental changes, pollution, and aquaculture practices, drives the demand for treatments and solutions. The expanding aquaculture sector, driven by the global demand for seafood, creates a substantial market for fish skin disease management products and services. Ongoing advancements in aquatic health management, including diagnostics, treatment modalities, and preventive measures, contribute to the growth of the fish skin disease market.  Regulatory bodies and governmental initiatives focused on sustainable aquaculture practices and fish health management drive the market for fish skin disease treatments.

However, effective treatment options for fish skin diseases may be limited, especially for certain infections or in specific aquatic environments. Environmental conditions, such as water quality, temperature, and pollution levels, can influence the prevalence and severity of fish skin diseases. Adverse ecological factors may hinder treatment effectiveness. The cost associated with implementing disease management protocols, including treatments and preventive measures, maybe a restraint for smaller fish farming operations with limited resources. Meeting regulatory standards for using treatments and chemicals in aquaculture settings is crucial, and compliance can be challenging for fish farmers and hence restraints the market.

By Type of Disease

  • Bacterial Infections
  • Parasitic Infections
  • Viral Infections
  • Fungal Infections

By Treatment Type

  • Antibiotics
  • Vaccines
  • Probiotics
  • Phage Therapy
  • Other Natural Treatments

By Fish Species

  • Salmon
  • Trout
  • Tilapia
  • Catfish
  • Others

By End User

  • Aquaculture Producers
  • Fisheries
  • Other Organizations Involved in Fish Production

By Region

  • Europe
  • North America
  • Asia Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of the region will also be provided in the final version of this market, which is based on the conclusion of primary interviews and secondary data points gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. Asia- Pacific registered the highest share in the market in 2022 Due to the rising global demand for fish as a vital protein source and the burgeoning aquaculture sector, the Asia-Pacific region experiences significant growth. Moreover, the region houses numerous fish farms and fisheries, potentially heightening the susceptibility to outbreaks of fish skin diseases due to densely populated living conditions and environmental factors. Conversely, North America is poised for notable expansion in the projected period. This is attributed to the increasing popularity of fish as a nutritious dietary option and the escalating incidence of fish skin diseases in the region. Notably, North America is home to various fish species, including salmon and trout, which are particularly prone to skin conditions, including bacterial infections and parasitic infestations. 

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Fish Skin Disease Market By Type of Disease, By Treatment Type, By Fish Species, By End User, and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape, mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.  Market Introduction
    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.  Research Methodology
    •   1. Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2. Primary Data
              1.2.1. Key Data from Primary Sources
        3. Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.  Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  Fish Skin Disease Market Variables, Trends & Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Market Overview
    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing focus of Fish Skin Disease Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  Fish Skin Disease Market Analysis Tools
    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Fish Skin Disease Market, By Type of Disease Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Bacterial Infections
        2. Parasitic Infections
        3. Viral Infections
        4. Fungal Infections

  • 8.  Fish Skin Disease Market, By Treatment Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Antibiotics
        2. Vaccines
        3. Probiotics
        4. Phage Therapy
        5. Other Natural Treatments

  • 9.  Fish Skin Disease Market, By Fish Species Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Salmon
        2. Trout
        3. Tilapia
        4. Catfish
        5. Others

  • 10.  Fish Skin Disease Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Aquaculture Producers
        2. Fisheries
        3. Other Organizations Involved in Fish Production

  • 11.  North America Fish Skin Disease Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. U.S.A
           2.2. Canada
           2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.  Latin America Fish Skin Disease Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. Brazil
           2.2. Venezuela
           2.3. Argentina
           2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.  Europe Fish Skin Disease Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
           2.6. Russia
           2.7. Poland
           2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.  Asia Pacific Fish Skin Disease Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. Japan
           2.2. China
           2.3. India
           2.4. Australia and New Zealand
           2.5. ASEAN
           2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.  Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. GCC
           2.2. Israel
           2.3. South Africa
           2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.  Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 17.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
    •   1. Zoetis Inc.
           1.1. Company Overview
           1.2. Product Portfolio
           1.3. SWOT Analysis
           1.4. Financial Overview
           1.5. Strategic Overview
        2. Elanco Animal Health
           2.1. Company Overview
           2.2. Product Portfolio
           2.3. SWOT Analysis
           2.4. Financial Overview
           2.5. Strategic Overview
        3. MSD Animal Health
           3.1. Company Overview
           3.2. Product Portfolio
           3.3. SWOT Analysis
           3.4. Financial Overview
           3.5. Strategic Overview
        4. Benchmark Holdings
           4.1. Company Overview
           4.2. Product Portfolio
           4.3. SWOT Analysis
           4.4. Financial Overview
           4.5. Strategic Overview
        5. Phibro Animal Health Corporation
           5.1. Company Overview
           5.2. Product Portfolio
           5.3. SWOT Analysis
           5.4. Financial Overview
           5.5. Strategic Overview
        6. Intervet Inc.
           6.1. Company Overview
           6.2. Product Portfolio
           6.3. SWOT Analysis
           6.4. Financial Overview
           6.5. Strategic Overview
        7. Norvartis
           7.1. Company Overview
           7.2. Product Portfolio
           7.3. SWOT Analysis
           7.4. Financial Overview
           7.5. Strategic Overview
        8. Merck Animal Health
           8.1. Company Overview
           8.2. Product Portfolio
           8.3. SWOT Analysis
           8.4. Financial Overview
           8.5. Strategic Overview
        9. Novartis AG
           9.1. Company Overview
           9.2. Product Portfolio
           9.3. SWOT Analysis
           9.4. Financial Overview
           9.5. Strategic Overview
        10. Pharmaq AS
           10.1. Company Overview
           10.2. Product Portfolio
           10.3. SWOT Analysis
           10.4. Financial Overview
           10.5. Strategic Overview
        11. AquaBounty Technologies
           11.1. Company Overview
           11.2. Product Portfolio
           11.3. SWOT Analysis
           11.4. Financial Overview
           11.5. Strategic Overview
        12. Alltech
           12.1. Company Overview
           12.2. Product Portfolio
           12.3. SWOT Analysis
           12.4. Financial Overview
           12.5. Strategic Overview
        13. Skretting
           13.1. Company Overview
           13.2. Product Portfolio
           13.3. SWOT Analysis
           13.4. Financial Overview
           13.5. Strategic Overview
        14. Nutreco
           14.1. Company Overview
           14.2. Product Portfolio
           14.3. SWOT Analysis
           14.4. Financial Overview
           14.5. Strategic Overview
        15. Biomin
           15.1. Company Overview
           15.2. Product Portfolio
           15.3. SWOT Analysis
           15.4. Financial Overview
           15.5. Strategic Overview

  • 18.  Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
            administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.  FutureWise SME Key Takeaway Points for Client
    •   

Partner

Our Clients